These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17082793)

  • 1. Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients.
    Brouwer E; Havenga MJ; Ophorst O; de Leeuw B; Gijsbers L; Gillissen G; Hoeben RC; ter Horst M; Nanda D; Dirven C; Avezaat CJ; Goudsmit J; Sillevis Smitt P
    Cancer Gene Ther; 2007 Feb; 14(2):211-9. PubMed ID: 17082793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
    Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
    J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
    Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
    Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.
    Holterman L; Vogels R; van der Vlugt R; Sieuwerts M; Grimbergen J; Kaspers J; Geelen E; van der Helm E; Lemckert A; Gillissen G; Verhaagh S; Custers J; Zuijdgeest D; Berkhout B; Bakker M; Quax P; Goudsmit J; Havenga M
    J Virol; 2004 Dec; 78(23):13207-15. PubMed ID: 15542673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector.
    Sakurai F; Mizuguchi H; Hayakawa T
    Gene Ther; 2003 Jun; 10(12):1041-8. PubMed ID: 12776162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
    Hoffmann D; Meyer B; Wildner O
    J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.
    Kuhlmann KF; van Geer MA; Bakker CT; Dekker JE; Havenga MJ; Elferink RP; Gouma DJ; Bosma PJ; Wesseling JG
    Cancer Gene Ther; 2009 Jul; 16(7):585-97. PubMed ID: 19180144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies.
    Särkioja M; Pesonen S; Raki M; Hakkarainen T; Salo J; Ahonen MT; Kanerva A; Hemminki A
    Gene Ther; 2008 Jun; 15(12):921-9. PubMed ID: 18401431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment.
    Hoffmann D; Wildner O
    Cancer Gene Ther; 2007 Jul; 14(7):627-39. PubMed ID: 17479104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved adenovirus vectors for infection of cardiovascular tissues.
    Havenga MJ; Lemckert AA; Grimbergen JM; Vogels R; Huisman LG; Valerio D; Bout A; Quax PH
    J Virol; 2001 Apr; 75(7):3335-42. PubMed ID: 11238859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity.
    Ophorst OJ; Kostense S; Goudsmit J; De Swart RL; Verhaagh S; Zakhartchouk A; Van Meijer M; Sprangers M; Van Amerongen G; Yüksel S; Osterhaus AD; Havenga MJ
    Vaccine; 2004 Aug; 22(23-24):3035-44. PubMed ID: 15297053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice.
    Sakurai F; Kawabata K; Koizumi N; Inoue N; Okabe M; Yamaguchi T; Hayakawa T; Mizuguchi H
    Gene Ther; 2006 Jul; 13(14):1118-26. PubMed ID: 16541121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient infection of primitive hematopoietic stem cells by modified adenovirus.
    Yotnda P; Onishi H; Heslop HE; Shayakhmetov D; Lieber A; Brenner M; Davis A
    Gene Ther; 2001 Jun; 8(12):930-7. PubMed ID: 11426333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
    Roberts DM; Nanda A; Havenga MJ; Abbink P; Lynch DM; Ewald BA; Liu J; Thorner AR; Swanson PE; Gorgone DA; Lifton MA; Lemckert AA; Holterman L; Chen B; Dilraj A; Carville A; Mansfield KG; Goudsmit J; Barouch DH
    Nature; 2006 May; 441(7090):239-43. PubMed ID: 16625206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gene transduction for experimental brain tumors using recombinant adenovirus vector].
    Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Ohmoto T; Yoshida Y; Hamada H
    No To Shinkei; 1998 Aug; 50(8):731-8. PubMed ID: 9757466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck cancer cells are efficiently infected by Ad5/35 hybrid virus.
    Suominen E; Toivonen R; Grenman R; Savontaus M
    J Gene Med; 2006 Oct; 8(10):1223-31. PubMed ID: 16941521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
    Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X
    Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.
    Ulasov IV; Rivera AA; Nettelbeck DM; Rivera LB; Mathis JM; Sonabend AM; Tyler M; Wang M; Douglas JT; Lesniak MS
    Int J Oncol; 2007 Nov; 31(5):1177-85. PubMed ID: 17912445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient gene transfer into hematopoietic cells by a retargeting adenoviral vector system with a chimeric fiber of adenovirus serotype 5 and 11p.
    Lu ZZ; Ni F; Hu ZB; Wang L; Wang H; Zhang QW; Huang WR; Wu CT; Wang LS
    Exp Hematol; 2006 Sep; 34(9):1171-82. PubMed ID: 16939810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells.
    Ulasov IV; Rivera AA; Han Y; Curiel DT; Zhu ZB; Lesniak MS
    J Neurosurg; 2007 Sep; 107(3):617-27. PubMed ID: 17886563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.